[PRM24] Scan: An Integrated System for Market Access of New Drugs in Italy
2011 Value in health
Lanati, E.P. | Lidonnici, D. | D'Ausilio, A. | Iorio, A. | Jommi, C. |
Objective of the SCAN project is to support pharma companies in Italy, in managing the complexity of the new drugs pricing process approval at both National and regional level, by identifying a fair price based on the real new drug value. The rationale behind SCAN is first to analyze in a structured and evidence based way all benefits related to a new drug vs a comparator, from clinical to pharmacoeconomic point of view, and then to get a fair price weighting all benefits with a National Board of expert who validate the whole process and result.